Screening tests can determine whether the baby is more or less likely to have certain birth defects or genetic disorders, which may be inherited. Screening results along with other risk factors, such as a woman's age and a couple's ethnic background and family history of genetic disorders, are used to calculate the odds that the fetus might be born with certain genetic disorders, such as Down syndrome, cystic fibrosis, Tay-Sachs disease, or sickle cell anemia.
This non-invasive prenatal test ()NIPT for pregnant women which estimates the risk of a fetus having Down’s syndrome (T21), Edward’s syndrome (T18) and Patau’s Syndrome (T13). This is an advanced screening test carried out on a small blood sample taken from the mother’s arm with no risk of miscarriage. Fetal sex determination is available optionally in regions where fetal sex determination is permitted. Please ask your healthcare professional for further information.Learn More
The test is performed by analysing cell-free placenta-fetal DNA from a maternal blood sample, with test results available in as little as 3 days. Allowing pregnant women fast, reliable results and reducing the need for invasive tests and the associated stress and anxiety.Learn More